AT332530B - Verfahren zur herstellung von stoffgemischen fur pharmazeutische zwecke - Google Patents

Verfahren zur herstellung von stoffgemischen fur pharmazeutische zwecke

Info

Publication number
AT332530B
AT332530B AT99173*#A AT99173A AT332530B AT 332530 B AT332530 B AT 332530B AT 99173 A AT99173 A AT 99173A AT 332530 B AT332530 B AT 332530B
Authority
AT
Austria
Prior art keywords
mixtures
preparation
pharmaceutical purposes
pharmaceutical
purposes
Prior art date
Application number
AT99173*#A
Other languages
German (de)
English (en)
Other versions
ATA99173A (de
Inventor
Karl Heinrich Pegel
Original Assignee
Liebenberg R W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liebenberg R W filed Critical Liebenberg R W
Publication of ATA99173A publication Critical patent/ATA99173A/de
Application granted granted Critical
Publication of AT332530B publication Critical patent/AT332530B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT99173*#A 1972-02-03 1973-02-05 Verfahren zur herstellung von stoffgemischen fur pharmazeutische zwecke AT332530B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA720698A ZA72698B (en) 1972-02-03 1972-02-03 Method of preparing medicinal compositions

Publications (2)

Publication Number Publication Date
ATA99173A ATA99173A (de) 1976-01-15
AT332530B true AT332530B (de) 1976-10-11

Family

ID=25564442

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99173*#A AT332530B (de) 1972-02-03 1973-02-05 Verfahren zur herstellung von stoffgemischen fur pharmazeutische zwecke

Country Status (12)

Country Link
AT (1) AT332530B (OSRAM)
AU (1) AU468003B2 (OSRAM)
BE (1) BE794027A (OSRAM)
CA (1) CA1028952A (OSRAM)
DE (1) DE2303247A1 (OSRAM)
ES (1) ES410733A1 (OSRAM)
FR (1) FR2173987B1 (OSRAM)
GB (1) GB1365661A (OSRAM)
IE (1) IE37464B1 (OSRAM)
IL (1) IL41289A (OSRAM)
NL (1) NL7301301A (OSRAM)
ZA (1) ZA72698B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2659466A1 (de) * 1976-12-30 1979-02-15 Roecar Holdings Nv Steroline und deren verwendung
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
JPS5874619A (ja) * 1981-10-29 1983-05-06 Nippon Shinyaku Co Ltd リポソ−ム及びその製法
DE3829643A1 (de) * 1988-09-01 1990-03-15 Roecar Holdings Nv Phyto- und zoosterole und deren derivate mit verbesserter wasserloeslichkeit
DE69213804T2 (de) * 1991-03-28 1997-03-27 Rooperol Na Nv Zusammensetzungen von Phytosterolen mit Phytosterolinen als Immunmodulatoren
SE512958C2 (sv) * 1998-04-30 2000-06-12 Triple Crown Ab Kolesterolsänkande komposition innehållande beta-sitosterol och/eller beta-sitostanol samt förfarande för dess framställning
SE517769C2 (sv) 1999-10-29 2002-07-16 Triple Crown Ab Kolesterol och blodfettsänkande komposition, innehållande fytosteroler, blandade med monoglycerider
US7306819B2 (en) 2002-06-12 2007-12-11 The Coca-Cola Company Beverages containing plant sterols
PT1549159E (pt) 2002-06-12 2008-12-23 Coca Cola Co Bebidas contendo esteróis vegetais
MY142989A (en) * 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
EP2238979A1 (en) * 2009-04-06 2010-10-13 LEK Pharmaceuticals d.d. Active pharmaceutical ingredient adsorbed on solid support

Also Published As

Publication number Publication date
NL7301301A (OSRAM) 1973-08-07
ZA72698B (en) 1973-09-26
ES410733A1 (es) 1976-04-01
FR2173987B1 (OSRAM) 1977-10-28
AU468003B2 (en) 1975-12-18
IL41289A0 (en) 1973-03-30
GB1365661A (en) 1974-09-04
DE2303247A1 (de) 1973-08-09
IE37464L (en) 1973-08-03
AU5106873A (en) 1974-07-18
ATA99173A (de) 1976-01-15
BE794027A (fr) 1973-05-02
IE37464B1 (en) 1977-08-03
CA1028952A (en) 1978-04-04
IL41289A (en) 1975-12-31
FR2173987A1 (OSRAM) 1973-10-12

Similar Documents

Publication Publication Date Title
AT332530B (de) Verfahren zur herstellung von stoffgemischen fur pharmazeutische zwecke
AT324524B (de) Verfahren zur herstellung von gerbstoff-formulierungen
AT327190B (de) Verfahren zur herstellung von 1-hydroxi-2-pyridonen
AT319931B (de) Verfahren zur Herstellung von N-(1-Äthyl-α-pyrrolidylmethyl)-2-methoxy-5-sulfamidobenzamid
AT321891B (de) Verfahren zur herstellung von 2-alkoxy-5-alkyl-sulfonylbenzoesäuren
AT330143B (de) Verfahren zur herstellung von 2-substituierten 4-hydroxy -2- cyclopenten -1- onen
AT320627B (de) Verfahren zur Herstellung von α-Deoxytetracyclinen
AT329536B (de) Verfahren zur herstellung von 2-alkoxy-5-alkylsulfonylbenzoesauren
DE2316050A1 (de) Verfahren zur herstellung von 2-hydroxyaethylimino-diacetonitril und 2-hydroxyaethylimino-diacetaten
AT336009B (de) Verfahren zur herstellung von 2-amino-2-oxazolinen
AT326648B (de) Verfahren zur herstellung von 2-nitro-benzofuranderivaten
AT331240B (de) Verfahren zur herstellung von 4-chlor-2-hydroxybenzothiazol
AT321269B (de) Verfahren zur Herstellung von p-Phenylendiamin
AT337163B (de) Verfahren zur herstellung von n-aminoathylbenzamiden
AT332875B (de) Verfahren zur herstellung von benzodiazepin -2-on- derivaten
AT321924B (de) Verfahren zur herstellung von 1-hydrazino-phthalazin-hydrochlorid
AT320657B (de) Verfahren zur Herstellung von 3-Phenyl-6-halogen-pyridazinverbindungen
AT328080B (de) Verfahren zur herstellung von 7-acylamido-7-alkoxycephalosporinverbindungen
AT321890B (de) Verfahren zur herstellung von 2-alkoxy-5-alkylsulfonybenzoesäuren
AT325611B (de) Verfahren zur herstellung von neuen benzopyran-derivaten
AT333261B (de) Verfahren zur herstellung von n-aminoalkylbenzamiden
AT317123B (de) Verfahren zur Herstellung von 3-Fluor-D-alanin
ATA573073A (de) Verfahren zur herstellung von benzocycloheptaoxazolonen
ATA938773A (de) Verfahren zur herstellung von n-aminoalkylbenzamiden
AT329776B (de) Verfahren zur herstellung von benzochinolizin-derivaten

Legal Events

Date Code Title Description
EIH Change in the person of patent owner
ELA Expired due to lapse of time
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties